Condition
Retina Disease
Total Trials
5
Recruiting
0
Active
0
Completed
2
Success Rate
66.7%-20% vs avg
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
Termination Rate
20.0%
1 terminated out of 5 trials
Success Rate
66.7%
-19.8% vs benchmark
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
67% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (3)
P 3 (1)
Trial Status
Completed2
Terminated1
Not Yet Recruiting1
Unknown1
Trial Success Rate
66.7%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07143851Not Yet RecruitingPrimary
Multi-modal Intelligent Diagnosis System for Multiple Ophthalmic Diseases
NCT05532410Not ApplicableCompletedPrimary
Optic Disc Photograph Collection Study
NCT05701124Phase 3CompletedPrimary
Intravitreal Ranibizumab Injection for Aggressive Versus Type 1 Prethreshold Retinopathy of Prematurity
NCT05624593Not ApplicableUnknown
P200TE and Predicate Agreement and Precision Study
NCT05536401Not ApplicableTerminatedPrimary
P200TE Agreement and Precision Study
Showing all 5 trials